Sponsors and contract research organisations can use the cross-trial functionality to communicate with sites across different studies, geographic locations and site roles.

IQVIA said that the new features decrease site workload through distribution and tracking of necessary clinical trainings and safety notifications across all trials.

The capabilities are available via a dashboard that enables users to push and track trainings and safety notifications. They can be accessed by all IQVIA full-service clinical studies.

IQVIA Global Technology Solutions senior vice-president Tal Rosenberg said: “Our latest platform upgrades help ensure that sponsors, IQVIA, and other CROs can notify sites about safety events and trainings from one centralised dashboard, while removing duplicative activities that were previously inherent in the process. Simply put, this makes it easier for everyone.”

The company added that the new capabilities facilitate transparency in audit-trail documentation by automatic tracking of notification, acknowledgement.

In addition, the features are claimed to save cost and time, mitigate audit and legal liability, as well as help in automatic detection of noncompliant site personnel for training and safety acknowledgement.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Formed as a result of merger between IMS Health and Quintiles, IQVIA offers advanced analytics, technology solutions and contract research services for the life sciences industry.

The company uses human data science to facilitate enhancement of new clinical development and commercialisation techniques, and improve healthcare outcomes.